Response to: 'Statins in systemic lupus erythematosus' by Abud-Mendoza.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Response to: 'Statins in systemic lupus erythematosus' by Abud-Mendoza.Published in
Ann Rheum Dis 2019; 78(5):e43PMID
29358283ae974a485f413a2113503eed53cd6c53
10.1136/annrheumdis-2017-212902
Scopus Count
Collections
Related articles
- Statins in systemic lupus erythematosus.
- Authors: Abud-Mendoza C
- Issue date: 2018 Sep
- Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review.
- Authors: Fasano S, Margiotta DP, Navarini L, Pierro L, Pantano I, Riccardi A, Afeltra A, Valentini G
- Issue date: 2017 Dec
- Statins and lupus erythematosus.
- Authors: Noël B
- Issue date: 2004 Mar
- Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: A nationwide population-based cohort study.
- Authors: Yu HH, Chen PC, Yang YH, Wang LC, Lee JH, Lin YT, Chiang BL
- Issue date: 2015 Nov
- Risks and benefits of statins in lupus erythematosus.
- Authors: Noël B
- Issue date: 2004 Jan 12